BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28120243)

  • 1. Flow-metabolism uncoupling in the cervical spinal cord of ALS patients.
    Yamashita T; Hatakeyama T; Sato K; Fukui Y; Hishikawa N; Ohta Y; Nishiyama Y; Kawai N; Tamiya T; Abe K
    Neurol Sci; 2017 Apr; 38(4):659-665. PubMed ID: 28120243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxic stress visualized in the cervical spinal cord of ALS patients.
    Yamashita T; Hatakeyama T; Sato K; Fukui Y; Hishikawa N; Takemoto M; Ohta Y; Nishiyama Y; Kawai N; Tamiya T; Abe K
    Neurol Res; 2021 Jun; 43(6):429-433. PubMed ID: 33377424
    [No Abstract]   [Full Text] [Related]  

  • 3. Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis.
    Sala A; Iaccarino L; Fania P; Vanoli EG; Fallanca F; Pagnini C; Cerami C; Calvo A; Canosa A; Pagani M; Chiò A; Cistaro A; Perani D
    Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1117-1131. PubMed ID: 30617963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis.
    Van Weehaeghe D; Ceccarini J; Delva A; Robberecht W; Van Damme P; Van Laere K
    J Nucl Med; 2016 Aug; 57(8):1238-43. PubMed ID: 26940764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET.
    Turner MR; Hammers A; Al-Chalabi A; Shaw CE; Andersen PM; Brooks DJ; Leigh PN
    Brain; 2005 Jun; 128(Pt 6):1323-9. PubMed ID: 15843422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis.
    Marini C; Cistaro A; Campi C; Calvo A; Caponnetto C; Nobili FM; Fania P; Beltrametti MC; Moglia C; Novi G; Buschiazzo A; Perasso A; Canosa A; Scialò C; Pomposelli E; Massone AM; Bagnara MC; Cammarosano S; Bruzzi P; Morbelli S; Sambuceti G; Mancardi G; Piana M; Chiò A
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2061-71. PubMed ID: 27421971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Performance of Positron Emission Tomography for the Presurgical Evaluation of Patients with Non-lesional Intractable Partial Epilepsy: Comparison among 18F-FDG, 11C-Flumazenil, and 11C-Flumazenil Binding Potential Imaging Using Statistical Imaging Analysis.
    Komoto D; Iida K; Higaki T; Kaichi Y; Takauchi K; Arihiro K; Kakita A; Hirokawa Y; Awai K
    Hiroshima J Med Sci; 2015 Dec; 64(4):51-7. PubMed ID: 26964154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced [(18)F]FDG and [(11)C]flumazenil PET analysis for individual outcome prediction after temporal lobe epilepsy surgery for hippocampal sclerosis.
    Yankam Njiwa J; Gray KR; Costes N; Mauguiere F; Ryvlin P; Hammers A
    Neuroimage Clin; 2015; 7():122-31. PubMed ID: 25610774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined brain and spinal FDG PET allows differentiation between ALS and ALS mimics.
    Van Weehaeghe D; Devrome M; Schramm G; De Vocht J; Deckers W; Baete K; Van Damme P; Koole M; Van Laere K
    Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2681-2690. PubMed ID: 32314027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain Stem Glucose Hypermetabolism in Amyotrophic Lateral Sclerosis/Frontotemporal Dementia and Shortened Survival: An
    Zanovello M; Sorarù G; Campi C; Anglani M; Spimpolo A; Berti S; Bussè C; Mozzetta S; Cagnin A; Cecchin D
    J Nucl Med; 2022 May; 63(5):777-784. PubMed ID: 34503963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lowered cerebral glucose utilization in amyotrophic lateral sclerosis.
    Dalakas MC; Hatazawa J; Brooks RA; Di Chiro G
    Ann Neurol; 1987 Nov; 22(5):580-6. PubMed ID: 3501273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers.
    Tondo G; Mazzini L; Caminiti SP; Sarnelli MF; Corrado L; Matheoud R; D'Alfonso S; Cantello R; Sacchetti GM; Perani D; Comi C; De Marchi F
    Neuroimage Clin; 2022; 36():103222. PubMed ID: 36223668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG-PET correlates of cognitive impairment in ALS.
    Canosa A; Pagani M; Cistaro A; Montuschi A; Iazzolino B; Fania P; Cammarosano S; Ilardi A; Moglia C; Calvo A; Chiò A
    Neurology; 2016 Jan; 86(1):44-9. PubMed ID: 26590270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography in presurgical localization of epileptic foci.
    Csaba J
    Ideggyogy Sz; 2003 Jul; 56(7-8):249-54. PubMed ID: 12971120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of 11C-flumazenil positron emission tomography in intractable temporal lobe epilepsy.
    Padma MV; Simkins R; White P; Satter M; Christian BT; Dunigan K; Lee C; Jacobs M; Mukherjee J; Mantil JC
    Neurol India; 2004 Dec; 52(4):457-62. PubMed ID: 15626833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography neuroimaging in amyotrophic lateral sclerosis: what is new?
    Quartuccio N; Van Weehaeghe D; Cistaro A; Jonsson C; Van Laere K; Pagani M
    Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):344-54. PubMed ID: 25375229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis.
    Pagani M; Chiò A; Valentini MC; Öberg J; Nobili F; Calvo A; Moglia C; Bertuzzo D; Morbelli S; De Carli F; Fania P; Cistaro A
    Neurology; 2014 Sep; 83(12):1067-74. PubMed ID: 25122207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset.
    Cistaro A; Valentini MC; Chiò A; Nobili F; Calvo A; Moglia C; Montuschi A; Morbelli S; Salmaso D; Fania P; Carrara G; Pagani M
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):251-9. PubMed ID: 22089661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Binding Potential of Brain Adenosine A
    Hayashi S; Inaji M; Nariai T; Oda K; Sakata M; Toyohara J; Ishii K; Ishiwata K; Maehara T
    J Neurotrauma; 2018 Jan; 35(1):25-31. PubMed ID: 28728462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28.
    Zürcher NR; Loggia ML; Lawson R; Chonde DB; Izquierdo-Garcia D; Yasek JE; Akeju O; Catana C; Rosen BR; Cudkowicz ME; Hooker JM; Atassi N
    Neuroimage Clin; 2015; 7():409-14. PubMed ID: 25685708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.